BioSpace News Archive

Medtronic plc (NYSE:MDT) today announced four-year data from the IN.PACT Global study, which reinforce the long-term durability and safety of the IN.PACT™ Admiral™ drug-coated balloon (DCB) in patients with peripheral artery disease (PAD) in the superficial femoral (SFA) and popliteal arteries.

Today, Boston Scientific (NYSE: BSX) announced positive data for two devices within the peripheral drug-eluting product portfolio during separate late-breaking clinical trial presentations at Vascular InterVentional Advances (VIVA) meeting in Las Vegas

Men’s Liberty™ is sharing the top tips from their users after a diabetes diagnosis and the preferred solution to help men regain their freedom from male incontinence. According to the Center for Disease Control, about 10% of Americans have Type 2 diabetes

MicroMedicine, Inc., a life sciences technology company, today announced that it will be launching its patented one-of-a-kind white blood cell isolation technology, the Sorterra™ Cell Isolation System, at the 34th Annual SITC Conference.

Darren J. Birkelbach, President, announced that American International Chemical, a subsidiary of LBB Specialties, has entered into an exclusive distribution agreement with Evonik for Alkoxides in the U.S. pharmaceutical and nutrition markets.

Aptose Biosciences Inc. announced financial results for the three months ended September 30, 2019 and reported on corporate developments.

CV Sciences, Inc., a preeminent supplier and manufacturer of hemp cannabidiol products, announced its financial results for the quarter ended September 30, 2019.

Cara Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, announced financial results and operational highlights for the third quarter ended September 30, 2019.

Harvard Bioscience, Inc., announced financial results for the three and nine months ended September 30, 2019.

Avinger, Inc., a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease, reported results for the quarter ended September 30, 2019.